Role of stimulant replacement therapy in treating stimulant use disorders: Within the context of the COVID-19 pandemic.

Mak, William; Webb, Devon; Sutherland, Christy; Hirsh, Alana

Mak, William; Webb, Devon; Sutherland, Christy; Hirsh, Alana.

Mak W; Enhanced skills resident in Addiction Medicine at the University of British Columbia in Vancouver.
Webb D; Family medicine resident at the Vancouver Fraser site of the University of British Columbia.
Sutherland C; Medical Director of the PHS Community Services Society and Clinical Associate Professor in the Department of Family Medicine at the University of British Columbia, both in Vancouver. christy.sutherland@phs.ca.
Hirsh A; Clinical Assistant Professor in the Department of Family Medicine at the University of British Columbia.

Can Fam Physician ; 68(2): 109-111, 2022 02.

Article in English | MEDLINE | ID: covidwho-1703941

Subject(s)

COVID-19; Central Nervous System Stimulants; Substance-Related Disorders; Central Nervous System Stimulants/therapeutic use; Humans; Pandemics; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Substance-Related Disorders / COVID-19 / Central Nervous System Stimulants Limits: Humans Language: English Journal: Can Fam Physician Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google